(Q80089315)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404856%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Orlistat reverse fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis (NASH) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404856%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Osamah Hussein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404856%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Masha Grosovski

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404856%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Sorina Schlesinger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404856%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Sergio Szvalb

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404856%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Nimer Assy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404856%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

3 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404856%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404856%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404856%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404856%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

2512-2519

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17404856%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10620-006-9631-1

28 December 2019

exact match

0 references

cites work

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

1 reference

12 December 2020

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

1 reference

12 December 2020

Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease

1 reference

12 December 2020

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

12 December 2020

Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.

1 reference

12 December 2020

Treatment with orlistat reduces cardiovascular risk in obese patients

1 reference

12 December 2020

Prevalence of and risk factors for hepatic steatosis in Northern Italy

1 reference

12 December 2020

Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients

1 reference

12 December 2020

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial

1 reference

12 December 2020

Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study

1 reference

12 December 2020

Dietary fat, fatty acid composition in plasma and the metabolic syndrome

1 reference

12 December 2020

Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants

1 reference

12 December 2020

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

1 reference

12 December 2020

A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

Medical management of obesity

1 reference

12 December 2020

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

1 reference

12 December 2020

Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study

1 reference

12 December 2020

Fatty infiltration of liver in hyperlipidemic patients

1 reference

12 December 2020

Continuous monitoring of in vitro oxidation of human low density lipoprotein

1 reference

12 December 2020

Diet composition and the metabolic syndrome: what is the optimal fat intake?

1 reference

12 December 2020

Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial

1 reference

12 December 2020

Nonalcoholic steatohepatitis: a study of 49 patients

1 reference

12 December 2020

The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes

1 reference

12 December 2020

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

1 reference

12 December 2020

Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment

1 reference

12 December 2020

The metabolically obese, normal-weight individual revisited

1 reference

12 December 2020

A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group

1 reference

12 December 2020

Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3.

1 reference

12 December 2020

Type of dietary fat and insulin resistance.

1 reference

12 December 2020

Fasting in obesity: another cause of liver injury with alcoholic hyaline?

1 reference

12 December 2020

Role of cytochrome P4502E1-dependent formation of hydroxyethyl free radical in the development of liver damage in rats intragastrically fed with ethanol

1 reference

12 December 2020

1 reference

12 December 2020

Effect on Hepatic Morphology of Treatment of Obesity by Fasting, Reducing Diets and Small-Bowel Bypass

1 reference

12 December 2020

A prospective analysis of the HOMA model. The Mexico City Diabetes Study.

1 reference

12 December 2020

Association of nonalcoholic fatty liver disease with insulin resistance.

1 reference

12 December 2020